TP53 and pancreatic neoplasm: When tested on a panel of human pancreatic cancer cell lines in vitro, cells bearing the p53 conformational mutants R172H, I255N, G245S, and Y220C responded to statins, while cells bearing the p53 contact mutants R273H and R248W did not11.